Vinluan, Angel Mae .
HRN: 26-02-13 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/09/2024
CO-AMOXICLAV 625MG (TAB)
10/09/2024
10/15/2024
PO
1 Tab
BID
NSVD; PROM
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes